A PHASE 1/2 STUDY OF REGN5093 IN PATIENTS WITH MET-ALTERED ADVANCED NON-SMALL CELL LUNG CANCER

Administered By

Awarded By

Contributors

Start/End

  • January 2, 2020 - December 15, 2020